Apotex Manufacturing Violations Could Delay Launch of Taxotere Generic
This article was originally published in The Pink Sheet Daily
FDA warning letter cites continued violations of manufacturing regs; agency may put a hold on all pending drug applications.
You may also be interested in...
Jordan's Hikma Sees Double-digit Sales Growth In First Half, Continues Aggressive M&A Expansion In Middle East
Hikma, one of the fastest growing multinational pharmaceutical companies, reported group revenue Aug. 26 up 11.3 percent year-on-year for the first half of 2010. Diversified among branded, generic and injectables, the Jordanian drug maker attributed the growth to strong generics sales in the U.S
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.